Rare diseases
Investigational molecules
Locations
Back to Poland31 clinical trials in Nowy Targ, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study of RO7837195 injection compared to placebo to treat moderate to severe ulcerative colitis
PolandStudy on the Effectiveness and Safety of Obefazimod for Patients with Moderate to Severe Crohn's Disease After Inadequate Response to Other Treatments
PolandStudy of IMG-007 injection to treat moderate to severe atopic dermatitis in adults
PolandStudy to evaluate ATI-045 injection compared to placebo in adults with moderate to severe atopic dermatitis
PolandStudy on the Long-Term Effects of TEV-48574 (Duvakitug) for Adults with Moderate to Severe Ulcerative Colitis or Crohn's Disease
PolandStudy on the Effectiveness and Safety of Rosnilimab for Patients with Moderate to Severe Ulcerative Colitis
PolandStudy of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke
PolandStudy on the Effects of TEV-48574 for Adults with Moderate to Severe Ulcerative Colitis or Crohn's Disease
PolandStudy of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
PolandStudy on Deucravacitinib for Patients with Active Psoriatic Arthritis New to Biologic Treatments
PolandStudy on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults
PolandA study to evaluate the efficacy and safety of vixarelimab in patients with moderate to severe ulcerative colitis
PolandThe busiest research cities in the country
What the registry says about research in the country
Multiple clinical trials focusing on ulcerative colitis and Crohn's disease treatments, evaluating novel therapeutic agents including obefazimod, rosnilimab, and TEV-48574 for patients with moderate to severe conditions.
These studies aim to improve treatment options for patients who haven't responded well to conventional therapies.
Groundbreaking research investigating treatments for atherosclerotic cardiovascular disease and acute coronary syndrome, including studies on inclisiran and antiplatelet strategies.
These trials focus on reducing major adverse cardiovascular events and improving patient outcomes.
Innovative research examining treatments for gastroparesis and psoriatic arthritis, testing medications like naronapride and deucravacitinib.
These studies aim to address both digestive system disorders and inflammatory joint conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
